MoS<sub>2</sub>-Plasmonic Nanocavities for Raman Spectra of Single Extracellular Vesicles Reveal Molecular Progression in GlioblastomaMahsa Jalali, Sara Mahshid, Ruhong Zhou et al.|ACS Nano|2023Cited by 87
Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institutionM. Azoulay, Bassam Abdulkarim, Fabiano Santos et al.|Journal of Neuro-Oncology|2017Cited by 83
A Phase 2 Study of Neo-adjuvant Metformin and Temozolomide followed by Hypofractionated Accelerated RadioTherapy (HART) with Concomitant and Adjuvant Metformin and Temozolomide (TMZ) in Patients with GlioblastomaGeorge Shenouda, Bassam Abdulkarim, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 7
A Phase 2 Trial of Neoadjuvant Temozolomide (TMZ) Followed By Accelerated Hypofractionated Radiation Therapy (AHRT) and TMZ Followed By Adjuvant TMZ in Patients with Newly Diagnosed Glioblastoma (GBM): Long Term Survival and Toxicity AnalysisGeorge Shenouda, Bassam Abdulkarim, Luís Souhami et al.|International Journal of Radiation Oncology*Biology*Physics|2018Cited by 2
Prognostic Factors of Survival for Anaplastic GliomasMagali Lecavalier‐Barsoum, Bassam Abdulkarim, George Shenouda et al.|International Journal of Radiation Oncology*Biology*Physics|2014Cited by 0